Development of next-generation antibodies for therapeutics

Antibody-based therapeutics represent an important advancement in the progress of infectious disease therapy and cancer treatment options.

The discovery and development of monoclonal antibodies (mAbs) has led to an improved understanding of their therapeutic potential against emerging infectious diseases including COVID-19 and offers one of the most successful therapeutic strategies for cancer in recent years.

In this third edition eBook, we look at some of the successful discovery and development methods for next-generation monoclonal antibody-based therapeutics and vaccines.